Junshi Biosciences Announces the Phase 3 Study of JS005 (IL-17A) for the Treatment of Moderate to Severe Plaque Psoriasis Met Primary Endpoints
SHANGHAI, Sept. 07, 2025 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd…
Enovix Announces Completion of Warrant Dividend Program
September 05, 2025 18:08 ET Â | Source: Enovix Corporation Warrants Expired and…
New Fortress Energy Announces Second Quarter 2025 Results
NEW YORK--(BUSINESS WIRE)--New Fortress Energy Inc. (Nasdaq: NFE) (“NFE” or the “Company”)…
Helios Alliance Announces National Opioid Conference Featuring Former White House Drug Policy Director Dr. Rahul Gupta
September 05, 2025 16:45 ET Â | Source: Helios Alliance Mobile, Alabama ,…
Hisense Announces Third FIFA World Cup Sponsorship and Showcases RGB-MiniLED Technology at IFA 2025
BERLIN, Sept. 5, 2025 /PRNewswire/ -- Hisense, a leading brand in global…
Salesforce Announces Quarterly Dividend
SAN FRANCISCO--(BUSINESS WIRE)--Salesforce (NYSE: CRM), the world’s #1 AI CRM, today announced…
HUTCHMED Highlights Clinical Data to be Presented at the 2025 World Conference of Lung Cancer and the CSCO Annual Meeting 2025
September 04, 2025 20:00 ET Â | Source: HUTCHMED (China) Limited HONG KONG…
Myriad Genetics Announces Precise MRD Clinical Data Published in The Lancet Oncology
SALT LAKE CITY, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc.,…
Starburst Announces AI & Datanova 2025, the Global Virtual Summit for Trino, Data and AI Innovation
On October 22–23, Starburst brings together innovators shaping the next wave of…
Cango Inc. Announces August 2025 Bitcoin Production and Mining Operations Update
HONG KONG, Sept. 2, 2025 /PRNewswire/ --Â Cango Inc. (NYSE: CANG) ("Cango" or…